|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2020 RON | -1.94% |
|
-0.98% | +12.22% |
| 05-29 | S.C. Ropharma S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-28 | S.C. Ropharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 103M 22.48M 19.71M 18.22M 16.75M 31.61M 2.17B 32.12M 218M 85.39M 1.06B 84.43M 82.59M 3.65B | P/E 2024 |
-47.7x | P/E 2025 | 45x |
|---|---|---|---|---|---|
| Enterprise Value | 214M 46.66M 40.9M 37.81M 34.77M 65.61M 4.5B 66.66M 452M 177M 2.2B 175M 171M 7.59B | EV / Sales 2024 |
0.17x | EV / Sales 2025 | 0.13x |
| Free-Float |
34.75% | Yield 2024 * |
-
| Yield 2025 | - |
| 28/04/22 | S C Ropharma S A : OGSM & EGSM resolutions 28.04.2022 | PU |
| 23/03/22 | S C Ropharma S A : Notice of O&EGSM 28.04.2022 | PU |
| 27/01/22 | S C Ropharma S A : 2022 Financial calendar | PU |
| 1 day | -1.94% | ||
| 1 week | -0.98% | ||
| 3 months | +1.00% | ||
| 6 months | -0.98% | ||
| Current year | +12.22% |
| 1 week | 0.2 |  | 0.21 |
| 1 month | 0.2 | | 0.21 |
| Current year | 0.18 | | 0.23 |
| 1 year | 0.15 | | 0.23 |
| 3 years | 0.14 | | 0.23 |
| 5 years | 0.14 | | 0.24 |
| 10 years | 0.14 | | 0.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mihai Miron
CEO | Chief Executive Officer | 65 | - |
| Director of Finance/CFO | 54 | 01/01/2010 | |
Danut-Marian Ene
HRO | Human Resources Officer | 57 | 01/01/2012 |
| Director | Title | Age | Since |
|---|---|---|---|
Mihai Miron
CHM | Chairman | 65 | 01/01/2009 |
| Director/Board Member | 54 | 01/01/2007 | |
Florentina Miron
BRD | Director/Board Member | 70 | 01/01/2007 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.94% | -0.98% | +20.96% | +9.19% | 22.48M | |
| -0.02% | +0.85% | +3.91% | +11.29% | 6.64B | |
| -2.57% | -3.00% | -23.60% | +38.11% | 3.29B | |
| -3.07% | -4.62% | -32.23% | -20.20% | 3.14B | |
| -1.27% | -0.52% | -16.53% | -7.06% | 2.78B | |
| -0.26% | +2.96% | -4.20% | +44.96% | 2.26B | |
| +0.98% | +8.21% | -34.96% | -41.17% | 1.39B | |
| +0.15% | -1.33% | -3.88% | -3.74% | 1.33B | |
| 0.00% | -1.46% | +19.60% | +55.69% | 464M | |
| -0.64% | -1.53% | -38.28% | -69.32% | 359M | |
| Average | -0.86% | +1.85% | -10.92% | +1.77% | 2.17B | |
| Weighted average by Cap. | -0.97% | +3.17% | -12.29% | +7.28% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.32B 288M 252M 233M 215M 405M 27.78B 412M 2.79B 1.09B 13.59B 1.08B 1.06B 46.83B | 1.54B 335M 293M 271M 249M 471M 32.29B 478M 3.24B 1.27B 15.8B 1.26B 1.23B 54.43B |
| Net income | -1.73M -376K -329K -304K -280K -528K -36.23M -537K -3.64M -1.43M -17.73M -1.41M -1.38M -61.08M | 2.18M 475K 416K 385K 354K 668K 45.8M 678K 4.6M 1.8M 22.41M 1.78M 1.74M 77.2M |
| Net Debt | 143M 31.03M 27.2M 25.14M 23.12M 43.62M 2.99B 44.32M 301M 118M 1.46B 117M 114M 5.04B | 111M 24.18M 21.19M 19.59M 18.02M 34M 2.33B 34.54M 234M 91.83M 1.14B 90.8M 88.82M 3.93B |
Employees
1,758
Sector
Drug Retailers
Calendar
08-31 -
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | RON 0.2020 | -1.94% | 171,086 |
| 16/07/26 | RON 0.2060 | -1.90% | 59,700 |
| 15/07/26 | RON 0.2100 | +0.96% | 13,233 |
| 14/07/26 | RON 0.2080 | +1.96% | 20,539 |
- Stock Market
- Stocks
- RPH Stock
Select your edition
All financial news and data tailored to specific country editions
